Global In-Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

Description

The global In-Vitro Diagnostics market size is expected to reach $ 150050 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).

The concentration of the market is relatively high, and the top  10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

This report studies the global In-Vitro Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for In-Vitro Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of In-Vitro Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global In-Vitro Diagnostics total market, 2018-2029, (USD Million)
Global In-Vitro Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: In-Vitro Diagnostics total market, key domestic companies and share, (USD Million)
Global In-Vitro Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global In-Vitro Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global In-Vitro Diagnostics total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global In-Vitro Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, Ortho Clinical Diagnostics and Becton Dickinson, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World In-Vitro Diagnostics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global In-Vitro Diagnostics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global In-Vitro Diagnostics Market, Segmentation by Type
    Tissue Diagnostics
    Professional Diagnostic
    Molecular Diagnostic
    Diabetes Monitoring
    Other

Global In-Vitro Diagnostics Market, Segmentation by Application
    Diabetes
    Infectious Diseases
    Oncology
    Cardiology
    HIV
    Other

Companies Profiled:
    Roche
    Abbott
    Danaher
    Siemens Healthineers
    Thermo Fisher Scientific
    Sysmex
    BioMerieux
    Ortho Clinical Diagnostics
    Becton Dickinson
    Bio-Rad Laboratories
    Hologic
    LifeScan
    Qiagen
    Wuhan Easy Diagnosis
    Wondfo
    KHB
    Hotgen
    Mindray
    Sinocare
    Getein Biotech

Key Questions Answered
1. How big is the global In-Vitro Diagnostics market?
2. What is the demand of the global In-Vitro Diagnostics market?
3. What is the year over year growth of the global In-Vitro Diagnostics market?
4. What is the total value of the global In-Vitro Diagnostics market?
5. Who are the major players in the global In-Vitro Diagnostics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 In-Vitro Diagnostics Introduction
    1.2 World In-Vitro Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World In-Vitro Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World In-Vitro Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States In-Vitro Diagnostics Market Size (2018-2029)
        1.3.3 China In-Vitro Diagnostics Market Size (2018-2029)
        1.3.4 Europe In-Vitro Diagnostics Market Size (2018-2029)
        1.3.5 Japan In-Vitro Diagnostics Market Size (2018-2029)
        1.3.6 South Korea In-Vitro Diagnostics Market Size (2018-2029)
        1.3.7 ASEAN In-Vitro Diagnostics Market Size (2018-2029)
        1.3.8 India In-Vitro Diagnostics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 In-Vitro Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 In-Vitro Diagnostics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World In-Vitro Diagnostics Consumption Value (2018-2029)
    2.2 World In-Vitro Diagnostics Consumption Value by Region
        2.2.1 World In-Vitro Diagnostics Consumption Value by Region (2018-2023)
        2.2.2 World In-Vitro Diagnostics Consumption Value Forecast by Region (2024-2029)
    2.3 United States In-Vitro Diagnostics Consumption Value (2018-2029)
    2.4 China In-Vitro Diagnostics Consumption Value (2018-2029)
    2.5 Europe In-Vitro Diagnostics Consumption Value (2018-2029)
    2.6 Japan In-Vitro Diagnostics Consumption Value (2018-2029)
    2.7 South Korea In-Vitro Diagnostics Consumption Value (2018-2029)
    2.8 ASEAN In-Vitro Diagnostics Consumption Value (2018-2029)
    2.9 India In-Vitro Diagnostics Consumption Value (2018-2029)

3 World In-Vitro Diagnostics Companies Competitive Analysis
    3.1 World In-Vitro Diagnostics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global In-Vitro Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for In-Vitro Diagnostics in 2022
        3.2.3 Global Concentration Ratios (CR8) for In-Vitro Diagnostics in 2022
    3.3 In-Vitro Diagnostics Company Evaluation Quadrant
    3.4 In-Vitro Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 In-Vitro Diagnostics Market: Region Footprint
        3.4.2 In-Vitro Diagnostics Market: Company Product Type Footprint
        3.4.3 In-Vitro Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: In-Vitro Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: In-Vitro Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: In-Vitro Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: In-Vitro Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: In-Vitro Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: In-Vitro Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based In-Vitro Diagnostics Companies and Market Share, 2018-2023
        4.3.1 United States Based In-Vitro Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies In-Vitro Diagnostics Revenue, (2018-2023)
    4.4 China Based Companies In-Vitro Diagnostics Revenue and Market Share, 2018-2023
        4.4.1 China Based In-Vitro Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies In-Vitro Diagnostics Revenue, (2018-2023)
    4.5 Rest of World Based In-Vitro Diagnostics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based In-Vitro Diagnostics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies In-Vitro Diagnostics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World In-Vitro Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Tissue Diagnostics
        5.2.2 Professional Diagnostic
        5.2.3 Molecular Diagnostic
        5.2.4 Diabetes Monitoring
        5.2.5 Other
    5.3 Market Segment by Type
        5.3.1 World In-Vitro Diagnostics Market Size by Type (2018-2023)
        5.3.2 World In-Vitro Diagnostics Market Size by Type (2024-2029)
        5.3.3 World In-Vitro Diagnostics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World In-Vitro Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Diabetes
        6.2.2 Infectious Diseases
        6.2.3 Oncology
        6.2.4 Cardiology
        6.2.5 Cardiology
        6.2.6 Other
    6.3 Market Segment by Application
        6.3.1 World In-Vitro Diagnostics Market Size by Application (2018-2023)
        6.3.2 World In-Vitro Diagnostics Market Size by Application (2024-2029)
        6.3.3 World In-Vitro Diagnostics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche In-Vitro Diagnostics Product and Services
        7.1.4 Roche In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Abbott
        7.2.1 Abbott Details
        7.2.2 Abbott Major Business
        7.2.3 Abbott In-Vitro Diagnostics Product and Services
        7.2.4 Abbott In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Abbott Recent Developments/Updates
        7.2.6 Abbott Competitive Strengths & Weaknesses
    7.3 Danaher
        7.3.1 Danaher Details
        7.3.2 Danaher Major Business
        7.3.3 Danaher In-Vitro Diagnostics Product and Services
        7.3.4 Danaher In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Danaher Recent Developments/Updates
        7.3.6 Danaher Competitive Strengths & Weaknesses
    7.4 Siemens Healthineers
        7.4.1 Siemens Healthineers Details
        7.4.2 Siemens Healthineers Major Business
        7.4.3 Siemens Healthineers In-Vitro Diagnostics Product and Services
        7.4.4 Siemens Healthineers In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Siemens Healthineers Recent Developments/Updates
        7.4.6 Siemens Healthineers Competitive Strengths & Weaknesses
    7.5 Thermo Fisher Scientific
        7.5.1 Thermo Fisher Scientific Details
        7.5.2 Thermo Fisher Scientific Major Business
        7.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Product and Services
        7.5.4 Thermo Fisher Scientific In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Thermo Fisher Scientific Recent Developments/Updates
        7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.6 Sysmex
        7.6.1 Sysmex Details
        7.6.2 Sysmex Major Business
        7.6.3 Sysmex In-Vitro Diagnostics Product and Services
        7.6.4 Sysmex In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Sysmex Recent Developments/Updates
        7.6.6 Sysmex Competitive Strengths & Weaknesses
    7.7 BioMerieux
        7.7.1 BioMerieux Details
        7.7.2 BioMerieux Major Business
        7.7.3 BioMerieux In-Vitro Diagnostics Product and Services
        7.7.4 BioMerieux In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 BioMerieux Recent Developments/Updates
        7.7.6 BioMerieux Competitive Strengths & Weaknesses
    7.8 Ortho Clinical Diagnostics
        7.8.1 Ortho Clinical Diagnostics Details
        7.8.2 Ortho Clinical Diagnostics Major Business
        7.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Product and Services
        7.8.4 Ortho Clinical Diagnostics In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Ortho Clinical Diagnostics Recent Developments/Updates
        7.8.6 Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
    7.9 Becton Dickinson
        7.9.1 Becton Dickinson Details
        7.9.2 Becton Dickinson Major Business
        7.9.3 Becton Dickinson In-Vitro Diagnostics Product and Services
        7.9.4 Becton Dickinson In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Becton Dickinson Recent Developments/Updates
        7.9.6 Becton Dickinson Competitive Strengths & Weaknesses
    7.10 Bio-Rad Laboratories
        7.10.1 Bio-Rad Laboratories Details
        7.10.2 Bio-Rad Laboratories Major Business
        7.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Product and Services
        7.10.4 Bio-Rad Laboratories In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Bio-Rad Laboratories Recent Developments/Updates
        7.10.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
    7.11 Hologic
        7.11.1 Hologic Details
        7.11.2 Hologic Major Business
        7.11.3 Hologic In-Vitro Diagnostics Product and Services
        7.11.4 Hologic In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Hologic Recent Developments/Updates
        7.11.6 Hologic Competitive Strengths & Weaknesses
    7.12 LifeScan
        7.12.1 LifeScan Details
        7.12.2 LifeScan Major Business
        7.12.3 LifeScan In-Vitro Diagnostics Product and Services
        7.12.4 LifeScan In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 LifeScan Recent Developments/Updates
        7.12.6 LifeScan Competitive Strengths & Weaknesses
    7.13 Qiagen
        7.13.1 Qiagen Details
        7.13.2 Qiagen Major Business
        7.13.3 Qiagen In-Vitro Diagnostics Product and Services
        7.13.4 Qiagen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Qiagen Recent Developments/Updates
        7.13.6 Qiagen Competitive Strengths & Weaknesses
    7.14 Wuhan Easy Diagnosis
        7.14.1 Wuhan Easy Diagnosis Details
        7.14.2 Wuhan Easy Diagnosis Major Business
        7.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Product and Services
        7.14.4 Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Wuhan Easy Diagnosis Recent Developments/Updates
        7.14.6 Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
    7.15 Wondfo
        7.15.1 Wondfo Details
        7.15.2 Wondfo Major Business
        7.15.3 Wondfo In-Vitro Diagnostics Product and Services
        7.15.4 Wondfo In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Wondfo Recent Developments/Updates
        7.15.6 Wondfo Competitive Strengths & Weaknesses
    7.16 KHB
        7.16.1 KHB Details
        7.16.2 KHB Major Business
        7.16.3 KHB In-Vitro Diagnostics Product and Services
        7.16.4 KHB In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 KHB Recent Developments/Updates
        7.16.6 KHB Competitive Strengths & Weaknesses
    7.17 Hotgen
        7.17.1 Hotgen Details
        7.17.2 Hotgen Major Business
        7.17.3 Hotgen In-Vitro Diagnostics Product and Services
        7.17.4 Hotgen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Hotgen Recent Developments/Updates
        7.17.6 Hotgen Competitive Strengths & Weaknesses
    7.18 Mindray
        7.18.1 Mindray Details
        7.18.2 Mindray Major Business
        7.18.3 Mindray In-Vitro Diagnostics Product and Services
        7.18.4 Mindray In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Mindray Recent Developments/Updates
        7.18.6 Mindray Competitive Strengths & Weaknesses
    7.19 Sinocare
        7.19.1 Sinocare Details
        7.19.2 Sinocare Major Business
        7.19.3 Sinocare In-Vitro Diagnostics Product and Services
        7.19.4 Sinocare In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Sinocare Recent Developments/Updates
        7.19.6 Sinocare Competitive Strengths & Weaknesses
    7.20 Getein Biotech
        7.20.1 Getein Biotech Details
        7.20.2 Getein Biotech Major Business
        7.20.3 Getein Biotech In-Vitro Diagnostics Product and Services
        7.20.4 Getein Biotech In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Getein Biotech Recent Developments/Updates
        7.20.6 Getein Biotech Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 In-Vitro Diagnostics Industry Chain
    8.2 In-Vitro Diagnostics Upstream Analysis
    8.3 In-Vitro Diagnostics Midstream Analysis
    8.4 In-Vitro Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World In-Vitro Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World In-Vitro Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World In-Vitro Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World In-Vitro Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World In-Vitro Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World In-Vitro Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World In-Vitro Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World In-Vitro Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World In-Vitro Diagnostics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key In-Vitro Diagnostics Players in 2022
    Table 12. World In-Vitro Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global In-Vitro Diagnostics Company Evaluation Quadrant
    Table 14. Head Office of Key In-Vitro Diagnostics Player
    Table 15. In-Vitro Diagnostics Market: Company Product Type Footprint
    Table 16. In-Vitro Diagnostics Market: Company Product Application Footprint
    Table 17. In-Vitro Diagnostics Mergers & Acquisitions Activity
    Table 18. United States VS China In-Vitro Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China In-Vitro Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based In-Vitro Diagnostics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies In-Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies In-Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 23. China Based In-Vitro Diagnostics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies In-Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies In-Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based In-Vitro Diagnostics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies In-Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies In-Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 29. World In-Vitro Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World In-Vitro Diagnostics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World In-Vitro Diagnostics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World In-Vitro Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World In-Vitro Diagnostics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World In-Vitro Diagnostics Market Size by Application (2024-2029) & (USD Million)
    Table 35. Roche Basic Information, Area Served and Competitors
    Table 36. Roche Major Business
    Table 37. Roche In-Vitro Diagnostics Product and Services
    Table 38. Roche In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Roche Recent Developments/Updates
    Table 40. Roche Competitive Strengths & Weaknesses
    Table 41. Abbott Basic Information, Area Served and Competitors
    Table 42. Abbott Major Business
    Table 43. Abbott In-Vitro Diagnostics Product and Services
    Table 44. Abbott In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Abbott Recent Developments/Updates
    Table 46. Abbott Competitive Strengths & Weaknesses
    Table 47. Danaher Basic Information, Area Served and Competitors
    Table 48. Danaher Major Business
    Table 49. Danaher In-Vitro Diagnostics Product and Services
    Table 50. Danaher In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Danaher Recent Developments/Updates
    Table 52. Danaher Competitive Strengths & Weaknesses
    Table 53. Siemens Healthineers Basic Information, Area Served and Competitors
    Table 54. Siemens Healthineers Major Business
    Table 55. Siemens Healthineers In-Vitro Diagnostics Product and Services
    Table 56. Siemens Healthineers In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Siemens Healthineers Recent Developments/Updates
    Table 58. Siemens Healthineers Competitive Strengths & Weaknesses
    Table 59. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 60. Thermo Fisher Scientific Major Business
    Table 61. Thermo Fisher Scientific In-Vitro Diagnostics Product and Services
    Table 62. Thermo Fisher Scientific In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Thermo Fisher Scientific Recent Developments/Updates
    Table 64. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 65. Sysmex Basic Information, Area Served and Competitors
    Table 66. Sysmex Major Business
    Table 67. Sysmex In-Vitro Diagnostics Product and Services
    Table 68. Sysmex In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Sysmex Recent Developments/Updates
    Table 70. Sysmex Competitive Strengths & Weaknesses
    Table 71. BioMerieux Basic Information, Area Served and Competitors
    Table 72. BioMerieux Major Business
    Table 73. BioMerieux In-Vitro Diagnostics Product and Services
    Table 74. BioMerieux In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. BioMerieux Recent Developments/Updates
    Table 76. BioMerieux Competitive Strengths & Weaknesses
    Table 77. Ortho Clinical Diagnostics Basic Information, Area Served and Competitors
    Table 78. Ortho Clinical Diagnostics Major Business
    Table 79. Ortho Clinical Diagnostics In-Vitro Diagnostics Product and Services
    Table 80. Ortho Clinical Diagnostics In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Ortho Clinical Diagnostics Recent Developments/Updates
    Table 82. Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
    Table 83. Becton Dickinson Basic Information, Area Served and Competitors
    Table 84. Becton Dickinson Major Business
    Table 85. Becton Dickinson In-Vitro Diagnostics Product and Services
    Table 86. Becton Dickinson In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Becton Dickinson Recent Developments/Updates
    Table 88. Becton Dickinson Competitive Strengths & Weaknesses
    Table 89. Bio-Rad Laboratories Basic Information, Area Served and Competitors
    Table 90. Bio-Rad Laboratories Major Business
    Table 91. Bio-Rad Laboratories In-Vitro Diagnostics Product and Services
    Table 92. Bio-Rad Laboratories In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Bio-Rad Laboratories Recent Developments/Updates
    Table 94. Bio-Rad Laboratories Competitive Strengths & Weaknesses
    Table 95. Hologic Basic Information, Area Served and Competitors
    Table 96. Hologic Major Business
    Table 97. Hologic In-Vitro Diagnostics Product and Services
    Table 98. Hologic In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Hologic Recent Developments/Updates
    Table 100. Hologic Competitive Strengths & Weaknesses
    Table 101. LifeScan Basic Information, Area Served and Competitors
    Table 102. LifeScan Major Business
    Table 103. LifeScan In-Vitro Diagnostics Product and Services
    Table 104. LifeScan In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. LifeScan Recent Developments/Updates
    Table 106. LifeScan Competitive Strengths & Weaknesses
    Table 107. Qiagen Basic Information, Area Served and Competitors
    Table 108. Qiagen Major Business
    Table 109. Qiagen In-Vitro Diagnostics Product and Services
    Table 110. Qiagen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Qiagen Recent Developments/Updates
    Table 112. Qiagen Competitive Strengths & Weaknesses
    Table 113. Wuhan Easy Diagnosis Basic Information, Area Served and Competitors
    Table 114. Wuhan Easy Diagnosis Major Business
    Table 115. Wuhan Easy Diagnosis In-Vitro Diagnostics Product and Services
    Table 116. Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Wuhan Easy Diagnosis Recent Developments/Updates
    Table 118. Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
    Table 119. Wondfo Basic Information, Area Served and Competitors
    Table 120. Wondfo Major Business
    Table 121. Wondfo In-Vitro Diagnostics Product and Services
    Table 122. Wondfo In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Wondfo Recent Developments/Updates
    Table 124. Wondfo Competitive Strengths & Weaknesses
    Table 125. KHB Basic Information, Area Served and Competitors
    Table 126. KHB Major Business
    Table 127. KHB In-Vitro Diagnostics Product and Services
    Table 128. KHB In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. KHB Recent Developments/Updates
    Table 130. KHB Competitive Strengths & Weaknesses
    Table 131. Hotgen Basic Information, Area Served and Competitors
    Table 132. Hotgen Major Business
    Table 133. Hotgen In-Vitro Diagnostics Product and Services
    Table 134. Hotgen In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Hotgen Recent Developments/Updates
    Table 136. Hotgen Competitive Strengths & Weaknesses
    Table 137. Mindray Basic Information, Area Served and Competitors
    Table 138. Mindray Major Business
    Table 139. Mindray In-Vitro Diagnostics Product and Services
    Table 140. Mindray In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Mindray Recent Developments/Updates
    Table 142. Mindray Competitive Strengths & Weaknesses
    Table 143. Sinocare Basic Information, Area Served and Competitors
    Table 144. Sinocare Major Business
    Table 145. Sinocare In-Vitro Diagnostics Product and Services
    Table 146. Sinocare In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Sinocare Recent Developments/Updates
    Table 148. Getein Biotech Basic Information, Area Served and Competitors
    Table 149. Getein Biotech Major Business
    Table 150. Getein Biotech In-Vitro Diagnostics Product and Services
    Table 151. Getein Biotech In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 152. Global Key Players of In-Vitro Diagnostics Upstream (Raw Materials)
    Table 153. In-Vitro Diagnostics Typical Customers
List of Figure
    Figure 1. In-Vitro Diagnostics Picture
    Figure 2. World In-Vitro Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World In-Vitro Diagnostics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World In-Vitro Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World In-Vitro Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company In-Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 13. In-Vitro Diagnostics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World In-Vitro Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India In-Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of In-Vitro Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for In-Vitro Diagnostics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for In-Vitro Diagnostics Markets in 2022
    Figure 27. United States VS China: In-Vitro Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: In-Vitro Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World In-Vitro Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World In-Vitro Diagnostics Market Size Market Share by Type in 2022
    Figure 31. Tissue Diagnostics
    Figure 32. Professional Diagnostic
    Figure 33. Molecular Diagnostic
    Figure 34. Diabetes Monitoring
    Figure 35. Other
    Figure 36. World In-Vitro Diagnostics Market Size Market Share by Type (2018-2029)
    Figure 37. World In-Vitro Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World In-Vitro Diagnostics Market Size Market Share by Application in 2022
    Figure 39. Diabetes
    Figure 40. Infectious Diseases
    Figure 41. Oncology
    Figure 42. Cardiology
    Figure 43. HIV
    Figure 44. Other
    Figure 45. In-Vitro Diagnostics Industrial Chain
    Figure 46. Methodology
    Figure 47. Research Process and Data Source

Companies Mentioned

Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech